ClinConnect ClinConnect Logo
Search / Trial NCT04040842

International Low Anterior Resection Score Evaluation

Launched by NATIONAL CANCER CENTER AFFILIATE OF VILNIUS UNIVERSITY HOSPITAL SANTAROS KLINIKOS · Jul 31, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Rectal Cancer Low Anterior Resection Low Anterior Resection Syndrome

ClinConnect Summary

The International Low Anterior Resection Score Evaluation trial is studying how bowel function changes in patients who undergo surgery for rectal cancer. Specifically, it looks at bowel function before surgery and again one year later, using a tool called the LARS score. This score helps to understand any issues patients may experience, like difficulty controlling bowel movements or having frequent urges to go to the bathroom. By comparing these scores, researchers want to see how surgery affects bowel function and how it compares to what is considered normal.

To participate in this trial, you need to be 18 years or older and planning to have surgery for rectal cancer with the goal of curing it. This includes various types of surgeries such as laparoscopic or robotic procedures. However, if you are undergoing surgery just for diagnosis, are receiving palliative care (treatment to relieve symptoms but not cure the disease), or have other specific conditions like dementia, you would not be eligible. If you join the study, you can expect to fill out questionnaires about your bowel function before your surgery and again one year later, helping to provide important information that could improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing rectal cancer surgery on curative intent.
  • Elective surgery patients.
  • Laparoscopic, laparoscopic-converted, robotic, TaTME (transanal total mesorectal excision) and open cases will be included.
  • Patients aged 18 years and over should be included.
  • Exclusion Criteria:
  • Patients undergoing a procedure purely for diagnosis or staging should be excluded.
  • Patients with palliative treatment.
  • Patients with recurrence should be excluded.
  • Patients with dementia
  • Patients who do not complete their treatment within 12 months of primary surgery e.g. including reversal of stoma, chemotherapy etc

About National Cancer Center Affiliate Of Vilnius University Hospital Santaros Klinikos

The National Cancer Center, an affiliate of Vilnius University Hospital Santaros Klinikos, is a leading institution dedicated to advancing cancer research and treatment. With a commitment to improving patient outcomes through innovative clinical trials, the center leverages its comprehensive expertise in oncology and state-of-the-art facilities to facilitate groundbreaking studies. By fostering collaboration among top researchers and healthcare professionals, the center aims to enhance the understanding of cancer and develop effective therapeutic strategies, ultimately contributing to global efforts in combating this complex disease.

Locations

Vilnius, , Lithuania

Patients applied

0 patients applied

Trial Officials

Joseph Nunoo-Mensah, MD

Study Director

King's College

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials